# CHOLESTYRAMINE
> **ANDA207294** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2024-11-21
## Drug
- **FDA Application Number:** ANDA207294
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CHOLESTYRAMINE
- **Generic name:** CHOLESTYRAMINE
- **Active ingredients:** CHOLESTYRAMINE
- **Dosage form:** POWDER
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MACLEODS PHARMS LTD
- **Manufacturer:** Macleods Pharmaceuticals Limited
- **First approval:** 2024-11-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207294)
---
*MORVS · CC0 1.0*